Author

Breana Galea

The University of Melbourne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:organoid / primary culture· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Alicia OshlackiD· 1 shared Anna DeFazioiD· 1 shared Anthony Simon HarveyiD· 1 shared Brialie Forster· 1 shared Briony Milesi· 1 shared Caitlin A. BennettiD· 1 shared Carolina SalazariD· 1 shared Catherine J. KennedyiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alicia OshlackORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deep tissue sequencing improves genetic diagnostic yield in focal cortical dysplasia

Breana Galea, Joshua Reid, Samuel Gooley, Tom Witkowski, Tara Lane, Sian Macdonald, Timothy E. Green, Zimeng Ye, Thiuni N. Adikari, Kristian John Bulluss, Saul Alator Mullen, Caitlin A. Bennett, Brialie Forster, Gabi Bradshaw, Wendi Lin, , Michael S. Hildebrand

This study uses deep sequencing to identify genetic variants in focal cortical dysplasias, finding pathogenic variants in 71% of cases and highlighting the importance of somatic variants in FCDIIb.

Progress in Neuro-Psychopharmacology and Biological Psychiatry · Aug 1, 2026Peer-reviewedGenetic & Genomic Medicine

Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid models

Olivia Craig, Carolina Salazar, Suad M. Abdirahman, Nikita Dalvi, Niveditha Rajadevan, Jennii Luu, Robert Vary, Susanne Ramm, Karla J. Cowley, Ratana Lim, Briony Milesi, Christopher Tagkalidis, Patricia Wojtowicz, Stuart Bencraig, Genevieve Dall, , Kylie L. Gorringe

This paper develops a large biobank of patient-derived MOC organoids and screens them for drug efficacy, finding resistance to standard therapies and effectiveness of less commonly used drugs.

bioRxiv · Apr 9, 2026 · PreprintCancer Biology